Eudaimonia Partners’s Adient ADNT Stock Holding History

Eudaimonia Partners’s Portfolio ADNT Stock Details ADNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-374	Closed	-$17K	–	393
2021 Q1	$17K	Buy	+374	New	+$14.1K	﹤0.01%	991

Other funds holding ADNT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

LAM

Lyrical Asset Management New York $6.56B AUM 20.06% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Eudaimonia Partners's ADNT Position: Q2 2021 in Review

Eudaimonia Partners sold out of Adient (ADNT) in Q2 2021, closing a stake of 374 shares — an estimated $17K sold.

Eudaimonia Partners first reported a position in ADNT in Q1 2021 and held it in 1 quarter. The position peaked at $17K in Q1 2021. 289 funds tracked by Wall St. Rank hold ADNT as of Q2 2021.

Eudaimonia Partners reported no remaining Adient position as of Q2 2021 after selling out during the quarter.
Eudaimonia Partners sold 374 Adient shares in Q2 2021, an estimated $17K.
Eudaimonia Partners first reported a position in Adient in Q1 2021 and held it in 1 quarter.
Eudaimonia Partners's Adient position peaked at $17K in Q1 2021.
289 funds tracked by Wall St. Rank held Adient as of Q2 2021.

Based on Eudaimonia Partners's 13F filing for Q2 2021, filed 13 Aug 2021.